Navigation Links
PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKesson's Patent Application
Date:9/1/2008

EDISON, N.J., Sept. 1 /PRNewswire/ -- PSKW, LLC, a New Jersey-based leading provider of prescription co-pay programs for the pharmaceutical industry, announced today that it has significantly expanded the scope of the lawsuit that it commenced last year in the Supreme Court of the State of New York, County of New York, against McKesson Specialty Arizona Inc. ("McKesson"), a wholly-owned subsidiary of McKesson Corporation. PSKW is now seeking, in addition to monetary damages, the assignment to PSKW of all right, title and interest in any McKesson patent applications or issued patents that incorporate, refer to or relate to, confidential and proprietary information and ideas that PSKW alleges McKesson misappropriated from PSKW's predecessor in interest, Touch Tone Media, Inc. ("Touch Tone")

According to PSKW President Robert Previdi (who was previously President of Touch Tone), "Our company works with major pharmaceutical companies, providing proprietary marketing concepts and technology that enables insured prescription patients to obtain their medications with little or no co-pay costs. The programs are sponsored by the pharmaceutical companies as a way to help people. Physicians play an important role in the program by providing these co-pay savings cards to their patients at the time they write out the prescriptions."

The lawsuit alleges that McKesson, in secret and without informing Touch Tone, used Touch Tone's trade secrets and other confidential and proprietary information that it had received from Touch Tone in confidence under a nondisclosure agreement in connection with a contemplated collaboration between the two companies, in order to set up its own competing co-pay offset program, in violation of the nondisclosure agreement and other legal rights of Touch Tone, and now of PSKW.

PSKW initially sought monetary damages and other forms of legal relief. Subsequent to the filing of its complaint, PSKW learned that McKesson had filed
'/>"/>

SOURCE PSKW, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ATS Medical Expands Open Pivot Heart Valve Offerings
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. BioLife Solutions Expands Scientific Advisory Board
4. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
5. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
6. Pharsight Expands Strategic Consulting Services Team
7. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
8. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
9. AQUISS Expands Into Significant New Territory
10. NanoBio Expands Drug Development Team for Its Anti-Infective Products
11. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... JOSE, California , January 15, 2014 ... cancer, today announced the appointment of Thomas C Reynolds MD, ... 20 years, development experience gained in the biotechnology industry, most ... "I am delighted to welcome Tom at this transformative time ...
(Date:1/15/2014)... A study has been launched to test whether ... could help to tackle the problem of obesity.  This unique ... surgery based in Stowmarket) and academics at University Campus Suffolk ... technology, which is inspired by equipment used to collect data ...
(Date:1/15/2014)... 15, 2014 The Microcompetition with Foreign DNA ... One of these latent viruses is the Epstein Barr Virus ... Rheumatoid arthritis (RA) is a chronic inflammatory disease that destroys ... found that RA patients have high concentrations of EBV DNA ...
(Date:1/15/2014)... Freeslate, Inc ., the leading ... Lupin Limited, one of India’s top five pharmaceutical companies, ... System for high throughput solid form screening. ... a wide range of quality, affordable generic and branded ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3
... at the 2008 Genitourinary Cancers Symposium, ... Inc. announced,today that the Company,s lead cancer ... was well-tolerated in combination with either docetaxel ... with,hormone refractory prostate cancer. Additionally, patients treated ...
... to household cleaners will benefit from new technologies and ... the National Institutes of Health (NIH) and the U.S. ... toxicity testing agreement. The concept behind this agreement is ... journal Science. , Two NIH institutes have formed ...
... 10 a.m.A summary of the National Nanotechnology Initiative (NNI) ... Nanoscale Science, Engineering, and Technology (NSET) Subcommittee of the ... report is a supplement to the Presidents Budget for ... budget request, as well as highlights of planned activities ...
Cached Biology Technology:OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 2OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 3OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 4NIH collaborates with EPA to improve the safety testing of chemicals 2NIH collaborates with EPA to improve the safety testing of chemicals 3National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights 2
(Date:4/17/2014)... Razzari of the nergie Matriaux Tlcommunications Research Centre ... John R. Evans Leaders Fund of the Canada ... state-of-the-art biotech and nanophotonics equipment. To this funding ... de l,Enseignement suprieur, de la Recherche, de la ... laboratories will help us develop new approaches for ...
(Date:4/17/2014)... Our eyes not ... with a continuous stream of information about our own movements. ... a car the world glides by us and leaves ... our brain calculates self-motion from this "optic flow". This way, ... during our own movements. Together with biologists from the University ...
(Date:4/17/2014)... eight years ago, Katia Silvera , a postdoctoral scholar ... on a field trip in a mountainous area in central ... seen before. , Unable to identify it, they contacted German ... out to be an unnamed species. So Carnevali recently named ... is the genus name, comprising about 40 species in the ...
Breaking Biology News(10 mins):New state-of-the-art biotech and nanotech equipment for INRS 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3
... this week in The Lancet Infectious Diseases ... bacterial infection that causes pneumonia, meningitis and sepsis ... a blood disorder prevalent in African children that increases ... study underscores the critical need for use of pneumococcal ...
... Could one of South America,s greatest military figures ... tuberculosis assumed at the time of his death in ... known as "El Libertador" or "The Liberator" ... Historical Clinicopathological Conference (CPC), sponsored by the University of ...
... 2010) Eighty percent of health problems and five million ... water and sanitation according to the World Water Development Report ... for rural villagers, highlights a dire need for reliable access ... aims to solve. The Lemelson-MIT Program today announced ...
Cached Biology News:Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 2Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 3Historic medical conference finds Bolivar may have been poisoned 2Historic medical conference finds Bolivar may have been poisoned 3Historic medical conference finds Bolivar may have been poisoned 4Inventor honored for tech improving access to clean water, healthcare, and business development in India 2Inventor honored for tech improving access to clean water, healthcare, and business development in India 3Inventor honored for tech improving access to clean water, healthcare, and business development in India 4
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: Western Blot...
... (MUC3) is a glycoprotein. distributed in ... extent in breast, lung and salivary gland ... cross-reaction with MUC1 and MUC2. ... Immunogen: MUC3 tandem repeat peptide ...
... caudal-related homeobox family, is an intestine-specific transcription ... in intestinal epithelial cells. It plays an ... phenotype of differentiated villus enterocytes as well ... Clone CDX2-88 reacts with a conserved epitope ...
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Biology Products: